√业绩说明会 □媒体采访 □现场参观 新疆科力新技术发展股份有限公司 证券代码：920088 证券简称：科力股份 公告编号：2025-031 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 5 月 13 日 15:30-17:00 活动地点：新疆科力新技术发展股份有限公司（以下简称"公司"）于 2025 年 5 月 13 日（星期二）15:30-17:00 在全景网"投资者关系互动平台" （https://ir.p5w.net）采用网络远程的方式召开 2024 年年度报告业绩说明会。 参会单位及人员：通过网络方式参加公司 2024 年年度报告业绩说明会的投 资者。 上市公司接待人员：公司董事长、总经理：赵波先生；公司董事、副总经理： 卜魁勇先生；公司董事、副总经理：徐晓红女士；公司财务总监：马红梅女士； 公司董事会秘书：宋小青女士；东莞证券保荐 ...

21世纪经济报道记者 唐唯珂 广州报道 近日，社交平台有消息传出，永旺广州天河城店将在今年6月正式歇业。永旺方面5月14日晚间回复21世 纪经济报道记者表示，合同双方还在沟通中，后续如有消息会官方发布。 根据永旺（香港）百货有限公司发布的2024年报，永旺和广东天河城（集团）股份有限公司签订的租赁 协议，租期将于2025年6月30日到期。 消息传出后，当地网友纷纷在社交平台表达不舍，称这家店自己从小逛到大，见证过生活中许多重要时 刻，"小时候我爸带我去逛吉之岛，还去六楼七楼吃大家乐。去年爸爸走了，每次过去那边都会想起 来。" 广州天河城于1996年开业，是中国内地最早的购物中心之一。与广州天河城同步开业的吉之岛，是广州 最早的外资综合商超。1996年，永旺在广州天河城负一层开设了内地首家吉之岛超市。2013年，永旺将 旗下的"吉之岛""佳世客"统一更名为"AEON"永旺。凭借独特的日式经营风格、丰富的进口商品以及颇 具吸引力的促销活动，永旺迅速在广州零售市场站稳脚跟，至今已承载了广州人近29年的购物记忆。 近年来，永旺在中国多地的门店都在进行收缩调整。2023年年底，永旺关闭了深圳新城市店，该店是永 旺在深圳 ...

诸如这般因标识混乱引发的吐槽还有不少。比如，不少地方的公共卫生间标识晦涩难懂，要么是几何图形组合， 要么是抽象的艺术图案，还因此闹出不少尴尬。无论是让人凌乱的楼层，还是"男女不分"的厕所，其实都指向了一个 共同问题——标识设计的初衷究竟是什么？诚然，设计者可以追求高级感、突出创意性，但落脚点不应离开"人"这个 核心。公共标识是人们在外获取信息、寻求帮助的重要渠道，能看懂以便于遵守和沟通，才是最为基本也最为关键的 准则。 公共设施关乎城市的日常运转，体现一座城市的精细化治理水平。很多人们习以为常的通用标识，也都是从实践 中不断修正、完善而来的。仅就楼层标识来说，目前确实没有统一标准，但很多地方都曾提出，公共场所标识应当以 规范汉字为基本服务用字。不妨以此对标，将那些弯弯绕的标识做一些清理。 走进大型商超、车站机场等场所，五花八门的楼层标识常令人晕头转向。B层、G层、LG层、UG层、M层……不 少人发出灵魂疑问，"我究竟在哪儿！" 楼层标识成了不便之源，一大原因在于各个场所的标记规则缺乏统一标准。就拿最常见的L层来说，通常取"Level （层级）"的含义，指地面以上的层数；但有时L又被视作"Lobby（大厅）"的 ...

近年来，乳制品行业面临消费需求疲软、市场竞争加剧等多重挑战，行业整体承压。iFinD数据显示， 2024年，19家A股乳企中仅有6家归属于上市公司股东的净利润实现正增长。 "目前，我国已成为乳制品生产和消费大国，但与国际消费情况相比，我国乳制品人均消费量仍处于较 低水平，对标发达国家来看中国人均饮奶量提升空间巨大，加之国家出台相关政策大力支持乳制品行业 健康发展，乳制品市场规模有望持续扩大。"庄园牧场董事会秘书杨凯在回答投资者提问时表示。 对于乳制品行业未来发展方向，华龙证券股份有限公司行业分析师胡林向记者表示："乳制品未来还是 要加强产业链整合，向上游延伸至奶源基地建设，提高奶源可控性；向下游拓展至销售渠道和终端市 场，提升品牌影响力和市场竞争力。通过全产业链布局，企业能够更好地控制成本、保证产品质量，实 现协同发展。" 庄园牧场在奶源基地建设方面早有布局。公司于2009年末以来陆续兴建标准化、规模化的自有养殖牧 场。截至目前，庄园牧场拥有10座现代化牧场集群，其中7座牧场获评"国家学生饮用奶奶源基地"。 庄园牧场成立于2000年，是一家集奶牛养殖、技术研发、乳品加工、销售为一体的专业化乳制品生产企 业，产 ...

美凯龙5月13日晚间公告，公司接到公司董事车建兴家属的通知，于近日收到云南省监察委员 会电话通知，对车建兴立案调查并实施留置措施。截至目前，公司尚未收到任何书面形式《留 置通知书》《立案通知书》，亦未收到云南省监察委员会需要协助调查或提供任何资料的要 求。 同时，为保证公司日常经营工作顺利进行，由美凯龙董事长李玉鹏在此期间代行总经理全部职 责。截至本公告日，公司其他董事、监事和高级管理人员均正常履职。公司组织架构及内部控 制机制完善，公司董事会运作正常。公司控制权未发生变化。 据此，公告称"日常经营情况正常，上述事项不会对公司日常经营活动产生重大影响。" 此次事件也引发外界对美凯龙经营情况的关注。自2023年入主后，建发股份在不到半年的时 间便从管理团队、经营管理、业务发展等多个维度对美凯龙进行全面接管、全面升级。根据公 开信息， 建发股份及其一致行动人目前共持有美凯龙29.95%股份，是第一大股东 。 在管理团队方面，美凯龙新一届董事会由14名董事组成，其中建发方面拿下5个非独董席位， 同时5位独立董事也是由建发方面提名。现任董事长李玉鹏由建发方面派驻。 过去近两年，面对房地产行业持续承压，美凯龙积极探索与 ...

Group 1: Company Overview - The company has seen significant revenue growth and steady profit improvement in its GNC China business, but there is still room for optimization in expense management [1] - The company plans to actively explore the potential of commercial contract promotion and implement various measures to reduce costs and improve efficiency, focusing on precise allocation of sales expenses [1] - The company aims to strengthen brand value and promote compliant, high-quality development of its GNC China business while closely monitoring market dynamics [1] Group 2: Market and Product Development - The orthopedic external patch market in China has exceeded 10 billion, with a compound annual growth rate of 9.55% driven by aging population and chronic disease management awareness [2] - The company is focusing on the development of traditional Chinese medicine combined with modern transdermal technology for its key prescription product, the wind-dispelling pain gel [2] - The company plans to continue digital and intelligent transformation of its traditional Chinese medicine production lines to enhance efficiency and responsiveness to national policy [2] Group 3: Future Product Pipeline - The company has received approval for a generic drug, lactulose oral solution, and is progressing with two other products through consistency evaluation [2] - Upcoming products expected to be approved in the next two years include oseltamivir phosphate dry suspension and iron protein succinate oral solution, among others [2] - The company will focus on major disease areas such as cardiovascular, digestive metabolism, respiratory, anti-infection, and anti-tumor, with an emphasis on developing medications for the elderly and children [2] Group 4: Financial Management - The company disclosed that its interest income comes solely from bank deposits, with no involvement in financial products or lending for interest income [3] - The company emphasizes a scientific and reasonable financial planning approach to maintain sufficient debt repayment capacity and a reasonable capital structure [3] - The company has established a budget management system to ensure that every expense has a responsible party and approval process, with regular evaluations and adjustments [3][4]

Core Viewpoint - The company, Furuida, reported a strong performance in Q1 2025, with significant growth in its core brand Yilian and a focus on brand enhancement and technological innovation amidst a volatile external environment [1][2]. Group 1: Financial Performance - In Q1 2025, the company achieved a revenue of 876 million yuan and a net profit of 50.71 million yuan, aligning with market expectations [2]. - The cosmetics segment generated a revenue of 526 million yuan with a gross margin of 61.1%, indicating strong profitability [2][3]. Group 2: Brand and Product Development - The Yilian brand recorded a revenue of 250 million yuan, a 25% year-on-year increase, with spray product sales surging by 69% [2]. - The company plans to focus on its two main brands, Yilian and Aier Doctor, and enhance product lines in sprays, probiotics, and collagen to drive growth [2]. Group 3: Research and Development - The company invested approximately 42 million yuan in R&D in Q1 2025, focusing on new product development and technological breakthroughs across cosmetics, pharmaceuticals, and raw materials [3]. - The company has achieved 12 new patent authorizations and launched 47 new products in the first quarter [3]. Group 4: Pharmaceutical and Raw Material Business - The pharmaceutical segment generated a revenue of 108 million yuan, remaining stable year-on-year, with a gross margin of 54.8% [3]. - The raw materials and additives segment achieved a revenue of 86 million yuan, a 2.4% increase year-on-year, with a gross margin rising nearly 10 percentage points to 39.54% [3].

Core Insights - The establishment of the Ningbo Tonggao Gongrong Private Equity Investment Fund marks a significant development in the financial landscape of Ningbo, with a registered scale of 2 billion yuan, making it the largest single AIC equity investment fund in the city [1] - The fund aims to focus on eight key industrial sectors, including digital industry, artificial intelligence, new energy vehicles, high-end equipment manufacturing, biomedicine, new materials, fine chemicals, and modern productive services [1][2] - The Industrial and Commercial Bank of China (ICBC) has cumulatively registered AIC equity investment funds totaling 5 billion yuan in Ningbo, positioning itself as the leading commercial bank in the city [1] Investment Strategy - The Ningbo Tonggao Gongrong Private Equity Investment Fund is a collaborative effort involving ICBC Financial Asset Investment Co., Ningbo Tongshang Holding Group Co., and Ningbo High-tech Venture Capital Co., focusing on precision investment and nurturing to attract quality resources for regional industrial upgrades [1][2] - Following the expansion of the financial asset investment company's equity investment pilot program, ICBC Ningbo Branch has successfully launched its first equity investment project under the Ningbo Gongrong New Momentum Fund, indicating a proactive approach to leveraging policy opportunities [2] - The bank plans to continue utilizing its comprehensive advantages to support key industries in Ningbo, emphasizing the importance of "long-term capital," "patient capital," and "strategic capital" in fostering technological innovation [2]

□ 本报记者 徐睿翔 5月13日，《政风热线·市长上线》全媒体直播走进南京，南京市市长陈之常带领各区政府以及市相关职 能部门主要负责人，现场倾听民声，回应市民关切。 几十辆外卖电动车随意停放，占据两股机动车道，不时有外卖小哥停车、跨栏取餐……这是当天节目中 的一幕画面。在南京一些交通繁忙、人流密集地段，不少外卖骑手经常遭遇"临停"难题。此前，南京在 一些商业体旁为外卖骑手和快递小哥施划了专用停车泊位，但实际中，有的专用泊位被其他非机动车占 据，有的骑手认为泊位太远而不愿停。 "这体现出我们管理上存在问题。"南京市城市管理局局长金安凡提出解决方案：一是全面梳理已施划的 泊位，调整不科学不合理的泊位；二是加大管理力度，将非机动车专用泊位管理纳入商家"门前三包"责 任范围，城管部门将把专用泊位管理纳入城管网格化巡查重点内容；三是鼓励商家在规划红线范围内设 置更多专用泊位。 网约车司机同样面临"临停"难题。"我们正和城管部门加强对道路的勘察，力争多划一些临停点位，缓 解供需矛盾。"南京市公安局常务副局长王秉德说，对于司机反映的因临停被贴罚单的情况，交管部门 将先短信通知，尽量劝离免予处理。 近年来，南京出台多项人才政 ...

Group 1 - The trend of refined parenting is emerging as a new generation of parents, primarily those born in the 1990s and 2000s, are driving changes in child-rearing concepts and consumption patterns, leading to an increased demand for children's skincare products [1] - The baby and toddler skincare market in China is expected to reach nearly 50 billion yuan by 2026, with the skincare segment projected to reach 18 billion yuan, expanding from basic cleaning and moisturizing to more functional areas such as sensitive skin, eczema, sun protection, and mosquito repellent [1] - Domestic beauty companies are increasingly entering the baby skincare market, with brands like Jichu launching products that address common skin issues in infants, such as eczema, through patented micro-ecological balance technology [1] Group 2 - Sales of baby skincare products on major e-commerce platforms are reaching new highs, with companies like Shiseido's subsidiary, Up Beauty, launching multiple baby skincare brands, including Red Elephant and Newpage, which reported significant revenue growth [4] - Newpage achieved a revenue of 376 million yuan in 2024, marking a year-on-year growth of 146.3%, while its revenue growth in 2023 was nearly five times [4] - Other brands like Winona Baby and Qichu are also gaining traction, with Winona Baby generating 201 million yuan in revenue in 2024, reflecting a year-on-year increase of 34.03% [4]